TNF Pharmaceuticals (TNFA) - Price Chart

Market fluctuations in TNF Pharmaceuticals (TNFA) shares reflect the dynamics of an asset currently valued at 5.16. TNF Pharmaceuticals develops anti-inflammatory agents, aiming to leverage the exclusivity of biological targets to maintain pricing power within the immunology treatment sector. The strategy focuses on drug discovery for age-related and orphan diseases, while small-molecule patent protection and strict FDA oversight create significant barriers to entry for competitors.

TNFA - TNF Pharmaceuticals Quote Chart over the range 07/25/2024 - 09/25/2025

TNF Pharmaceuticals - analytical breakdowns and key metrics (TNFA)

- current price and projected stock value:

Stock Quotes TNF Pharmaceuticals|TNFA - Analyst Forecast Prices

- market capitalization indicators:

Market Value TNF Pharmaceuticals, Inc.|TNFA - Business Value

- balance sheet equity data:

Book Value per Share TNF Pharmaceuticals|TNFA - Net Asset Value|Market Capitalization to Book Value Ratio tnfpharma.com|TNFA - Company Total Assets

- business debt structure and liquidity details:

- earnings and market ratios statistics:

TNFA - Net Income|Projected Future Earnings TNF Pharmaceuticals|TNFA - P/E Multiple|Projected Price to Earnings TNF Pharmaceuticals Inc.|TNFA - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TNF Pharmaceuticals Inc.|TNFA - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months TNF Pharmaceuticals|TNFA - Earnings per share for the last four quarters|Quarterly EPS earnings growth tnfpharma.com|TNFA - Earnings per share increase in current year|Earnings growth forecast for next year TNF Pharmaceuticals

- sales and revenue indicators:

TNFA - Company Total Revenue|Company Projected Revenue TNF Pharmaceuticals Inc.|TNFA - Market Capitalization-to-Revenue Ratio|Forward Price-to-Revenue Multiple TNF Pharmaceuticals Inc.|TNFA - Revenue Change YoY (Last 12 Months)

Fundamental valuation:TNF Pharmaceuticals Inc.

The price aggregates market expectations, measuring the current value of equity through the balance of supply and demand on the exchange. Amid the restructuring of TNF Pharmaceuticals (TNFA) and its dependence on clinical trial stages, market price fluctuations reflect investor confidence in the future commercialization of drugs, serving as an indicator of business resilience during the period of absent active sales.

Analysis of competing companies